战略与国际研究中心-The-Evolution-and-Future-of-HIV-Prevention-Technology--An-HIV-Policy-Primer_18页_6mb

Summary of "The Evolution and Future of HIV Prevention Technology"

Core Content

This document outlines the evolution of HIV prevention efforts, highlights the current state of prevention technology, and identifies the key challenges that hinder its widespread implementation. It emphasizes the importance of scaling up prevention tools to reduce the global HIV incidence, which has remained high despite progress in treatment.

Main Points

• Global HIV Statistics (2018):

  • 1.7 million new HIV infections
  • 61% of infections occurred in sub-Saharan Africa
  • 47% of adult infections occurred in women
  • 20% of adult infections occurred in young women aged 15-24
  • 37.9 million people living with HIV (PLHIV)
  • 700,000 AIDS-related deaths

• High-Risk Groups:

  • Men who have sex with men (MSM): 22 times higher risk
  • Sex workers: 21 times higher risk
  • Transgender people: 12 times higher risk

• Prevention Tools and Their Impact:

  • Prevention of Mother-to-Child Transmission (PMTCT): Prevented 1.4 million infections between 2010 and 2018
  • Voluntary Medical Male Circumcision (VMMC): Reduces female-to-male transmission by 60%, with 19 million men undergoing VMMC between 2010 and 2018
  • Treatment as Prevention (TasP): Reduces transmission by lowering viral load in PLHIV; the concept of "U=U" (undetectable = untransmittable) emerged from studies like HPTN 052 and PARTNER

• Pre-Exposure Prophylaxis (PrEP):

  • Oral PrEP: First demonstrated in the iPrEx study (2010) with TDF/FTC, reducing infection rates by 44% in MSM and transgender women
  • WHO Recommendations: Expanded in 2014 to include all high-risk populations
  • Global PrEP Usage (2018): Approximately 337,500 people on daily oral PrEP, with only 34% in sub-Saharan Africa
  • Coverage Gaps: PrEP is underutilized in high-risk areas, especially among adolescent girls and young women

• TasP Limitations:

  • Requires consistent adherence to daily medication
  • Stigma and low perceived risk are major barriers to adherence
  • Long-acting formulations (e.g., injectable and implantable PrEP) are in development to improve adherence and reduce stigma

• Community-Level Impact:

  • The PopART study showed that ART must be combined with VMMC and PrEP for significant impact on reducing infections
  • ART alone is insufficient for large-scale prevention

Key Challenges

• Lack of Discreet, User-Driven Tools: Traditional prevention methods like ABC and condoms are not always effective due to social and power dynamics
• Stigma and Discrimination: Prevents access and use of prevention tools, especially among women and key populations
• Structural Barriers:
  • Inadequate financing
  • Regulatory and guideline delays
  • Weak health systems
  • Insufficient demand creation among potential users
• Global Funding Trends:
  • HIV prevention R&D investment has declined for the past six years
  • In 2018, global investment in HIV prevention R&D was $1.14 billion
  • The U.S. government funded 73% of this, or $835 million
  • PEPFAR has been the largest bilateral funding source for HIV, but its focus has been heavily on treatment and care, with only 15.6% of its 2018 budget allocated to prevention

Future Directions

• Need for Political and Financial Commitment: Prevention must be a global priority to align with UNAIDS Fast Track goals
• Scaling Up Prevention Technologies: Requires addressing barriers to access, adherence, and implementation
• Innovative Prevention Tools: Long-acting formulations (injectable, implantable, and vaginal rings) are in development to improve user control and effectiveness
• Role of Donors: The U.S. government and the Global Fund play a crucial role in shaping national HIV strategies and funding allocations

Conclusion

Despite progress in HIV treatment, prevention remains underfunded and underprioritized globally. The combination of innovative technologies and robust implementation strategies is essential to achieving the goal of ending the HIV epidemic. Continued investment, policy reform, and community engagement are necessary to ensure these tools reach those who need them most.